產(chǎn)品詳情
  • 產(chǎn)品名稱:CD437

  • 產(chǎn)品型號(hào):
  • 產(chǎn)品廠商:Biovision
  • 產(chǎn)品文檔:
你添加了1件商品 查看購(gòu)物車
簡(jiǎn)單介紹:
CD437
詳情介紹:
Purpose A selective RARgamma agonist and stem cell fate modulator
Characteristics PubChem CID: 135411
CD437 is the adamantyl arotinoid of the retinoid-related molecule family that acts as a selective agonist of retinoic acid receptor (RAR)γ (Kds = 6.5 μM, 2.5 μM, and 77 nM for RARα, β, and γ, respectively). CD437 is cytotoxic to the acute myeloid leukemia cell line NB4 (EC?? = 0.17 μM), inducing DNA damage by producing DNA double strand breaks. CD437 also induces cell cycle arrest and apoptosis in various other cancer cells including melanoma, breast, non-small lung, and prostate cancer cells through RAR-dependent and -independent signaling pathways. Treatment of mouse embryonic fibroblasts (MEFs) with CD437 early in the reprogramming process significantly increases reprogramming efficiency up to 20-fold.
Synonyms: AHPN
Purity > 95?%
Chemical Name 6-?(4-?hydroxy-?3-?tricyclo[3.3.1.13,?7]dec-?1-?ylphenyl)-?2-?naphthalenecarboxylic acid; AHPN
Formula C??H??O?
Permeability Cell-permeable
Solubility DMSO (>10 mg/ml)
Molecular Weight 398.49 g/mol
CAS-No 125316-60-1
Restrictions For Research Use only
Format Solid
Handling Advice Protect from air and light
Storage -20 °C
Expiry Date 36 months
Supplier Images
 image for CD437 (ABIN1995239) CD437